Konakion Mm Paediatric 2 mg Ampoule
PDF Leaflet Revision Date: 20 July 2018
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and treatment of haemorrhagic disease of the newborn.
Dosage (summary)
2 mg orally at birth; 1 mg IM/IV for at-risk neonates.
Special Populations
- Premature infants
- Hepatobiliary disease
- Inability to swallow
Pregnancy & Breastfeeding
Safety and efficacy in pregnancy and lactation not demonstrated.
Key Drug Interactions
- Antagonises warfarin
Contraindications
- Hypersensitivity to constituents
Common side effects
- Tissue necrosis
- Anaphylactoid reactions
- Local irritation
Counselling Points
- Administer as directed
- Monitor for adverse reactions
- Store below 25 u00b0C
Serious warnings
- Increased risk of kernicterus in premature infants <2.5 kg
Important Disclaimer
The Konakion Mm Paediatric 2 mg Ampoule professional information leaflet below is the property of Pharmaco Distribution and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
